Human osteoblast cultures (hOB) were examined for the production of interstitial collagenase, tissue inhibitor of metalloproteinases (TIMP), and gelatinolytic enzymes. Cells were isolated by bacterial collagenase digestion of trabecular bone (vertebra, rib, tibia, and 
Introduction
Bone is a complex organ composed of many cell types including cells of mesenchymal origin as well as those ofthe immune system (1) . The 16 March 1989. blasts arise and infiltrate the superstructure, depositing matrix proteins including type I collagen, proteoglycans, fibronectin, osteonectin, and many others (2, 3) . This milieu is termed osteoid. After the osteoid is deposited by the osteoblasts, it becomes calcified, yielding the hard connective tissue of bone. During this process, some osteoblasts become embedded within the bone matrix and are called osteocytes, cells that help to maintain the integrity of bone. New bone is modeled by the activity of osteoclasts, cells of bone marrow mononuclear cell origin that fuse into multinucleated cells (4) (5) (6) . These specialized cells are capable of removing calcified osteoid and are thus responsible for the formation of the bone marrow cavity. Within the marrow cavity, the osteoblasts form islands of bone called trabeculae which give strength to the bone. Once formed, mature bone undergoes virtually continuous remodeling throughout the life of the organism. Teams of osteoclasts resorb microscopic quanta of tissue from the bony surfaces and, subsequently, osteoblasts are recruited to repair the resorption defect (7) .
When bone formation is complete, the osteoblasts then become quiescent and flatten out over the surface of bone. To initiate remodeling, it has been hypothesized that the flattened osteoblasts contract under the influence of resorption stimulative hormones such as PTH or PGE2, creating a void in the lining of the bone where osteoclasts attach and resorb the calcified matrix (8) (9) (10) (11) . In addition, in vitro studies have suggested that a thin layer of organic matrix which lines the mineralized bone surface must be removed in order for osteoclasts to be attracted and attach to the newly exposed surface (12, 13) . It has been hypothesized from studies on rodent bone cultures that osteoblasts, under the influence of bone-resorption-stimulating hormones, secrete interstitial collagenase which subserves the degradation of surface type I collagen and thereby promotes osteoclast attraction and attachment (12-18). Rodent osteoblasts have also been reported to secrete a protease inhibitor which may block the action of collagenase and perhaps other metalloenzymes (14, 19) , thereby providing more precise regulatory control over the process.
We have conducted this study to determine whether human osteoblasts in homogeneous monolayer culture are capable of secreting collagenase and tissue inhibitor of metalloproteinases (TIMP).' Our 
Methods
Cell cultures. Human bone cell cultures were prepared according to the method of Robey and Termine, with modification (2). Briefly, surgical specimens ofrib were split longitudinally and the marrow cavity rinsed extensively with serum-free medium (DME/Ham's F-12, 1:1, vol:vol). The trabecular bone was removed with a size 0 curette, minced and washed several times. The bone chips were then subjected to bacterial collagenase digestion (2 mg/ml, type IV) for 2 h at 27°C. The released cells were washed three times and then seeded into T-75 flasks (Costar, Cambridge, MA) in medium supplemented with 10% FBS (Sigma Chemical Co.). After reaching confluency, the cells were removed with trypsin-EDTA (0.05-0.02%, respectively, Sigma Chemical Co.), counted, and seeded at 2.5 X I04 cells per 16-mm well of24-well tissue culture plates (Costar) in 10% FBS-containing medium. The cells were then allowed to grow to confluency (4-8 wk) with medium changes every 3-4 d.
Normal human skin fibroblasts were purchased from American Type Culture Collection (Rockville, MD). The cells were grown in Dulbecco's modified Eagle's medium-HG + glutamine, 0.03 M Hepes buffer (pH 7.6), 10% fetal calfserum, and 200 U/ml ofpenicillin + 200 jug/ml of streptomycin. After two to three passages, the cells were grown to visual confluence, washed with HBSS, and cultured under serum-free conditions for 48 h.
Bone cell-conditioned medium. Confluent cell cultures were washed with fresh medium and the following hormones or chemicals added for the time period indicated in the relevant figure legends or tables: PMA, 1 X 10-8 M; PTH, human 1-34, 1 X 10-8 to 1 X l0-7 M; 1,25(OH)2 vitamin D3, 1 X 10-' M; epidermal growth factor (EGF), 10 ng/ml; recombinant human interleukin 1,B (rhIL-1,), 1-10 U/ml; and PGE2, I X 10-8 M. The conditioned media were collected and assayed for collagenase and TIMP by ELISA (see below). To obtain samples for the assay ofcollagenase and TIMP by functional activity, cultures were washed three times and refed with serum-free medium prior to the addition of the appropriate agents.
Assays
Assays for alkaline phosphatase. Human osteoblast cultures were grown to confluency in serum-containing medium in 16-mm wells of 24-well tissue culture plates. The cultures were then washed three times with phosphate-buffered saline, pH 7.4, and lysed in water by three freeze-thaw cycles. Immunologic assays of collagenase and TIMP. Collagenase and TIMP levels in the various conditioned media were measured by ELISA using specific polyclonal antisera prepared to the respective human fibroblast proteins as described previously (20, 21) . These assays have nanogram sensitivity, and quantify the total amount of each protein present, whether free or bound. TIMP assays performed on conditioned media containing 109%o FBS were calculated by subtracting 0.02 gg/ml for the small contribution of bovine TIMP that is present in serum minimally cross-reactive with human TIMP antibody.
Gel diffusion was performed in a 1.0% agar matrix as described by Ouchterlony (22).
Immunoprecipitation ofcollagenase, TIMP, and gelatinase. Metabolic labeling of newly synthesized bone cell proteins was accomplished by pulsing the osteoblasts with [35S]methionine (50 MCi/ml) in methionine-free nutrient media for 24 h. Specific polyclonal antisera to human fibroblast collagenase, TIMP, and gelatinase were then utilized for immunoprecipitation as described previously (23) .
Functional assay for collagenase. Guinea pig type I collagen was prepared by cold neutral salt extraction as described by Gross (24) . Bone cell-conditioned media, collected under serum-free conditions for 24-48 h, were concentrated by either of two methods: (a) dialysis against 2.5 mM Tris, pH 7.5, containing 0.5 mM CaC12, and subsequent lyophilization with the samples reconstituted in 1/20 vol of water; and (b) ultrafiltration using Centricon I0-kD filters (Amicon Corp., Danvers, MA). Samples were also analyzed without prior concentration. To activate latent collagenase, conditioned media samples were either treated with phenylmercuric chloride (final concentration 1 mM) or were exposed to trypsin (range 0.01-10 ug) for 10 min at room temperature followed by the addition of an eightfold molar excess ofsoybean trypsin inhibitor. Aliquots (100 zd) were then incubated with 30 Ml of collagen (0.4 Mg/Ml) at 25°C for 24 h in buffer containing 0.05 M Tris, 0.01 M CaC12, and 0.4 M NaCl, pH 7.5. The reactions were stopped by the addition of 70 Ml of SDS sample buffer containing EDTA and dithiothreitol, and the samples were boiled immediately. The samples were then subjected to polyacrylamide gel electrophoresis performed according to the method of King and Laemmli (25) with 9.0% polyacrylamide gels cast in slab molds. After electrophoresis, the protein bands were stained with 1% Coomassie blue. Samples were also analyzed for the capacity to degrade native, reconstituted collagen fibrils (biosynthetically labelled with ['4C]glycine) at 37°C.
Functional assay for TIMP. TIMP was partially purified by subjecting osteoblast conditioned, serum-free media (200 ml) to dialysis against 0.05 M Tris, pH 7.5, and subsequent ion exchange chromatography using a 10 X 2.5 cm column of phosphocellulose (P-l 1, Whatman Inc., Clifton, NJ). TIMP binds avidly to this matrix, whereas serum antiproteases such as a2-macroglobulin fall through (26) . The bound TIMP was eluted with 0.5 M (NH4)2SO4, dialyzed against 0.005 M Tris, pH 7.5, and lyophilized to achieve a 20-fold concentration.
The partially purified TIMP preparation was then assayed for the capacity to inhibit pure human fibroblast collagenase (21) . Human fibroblast collagenase was purified to homogeneity as described previously (27) , activated proteolytically with trypsin, and tryptic activity was terminated by the addition of SBTI. Inhibition of collagenase activity was measured at 37°C using native, reconstituted, biosynthetically ['4C]glycine-labeled guinea pig skin collagen as substrate (28). 50 Ml ofa 0.4% collagen solution was allowed to form an insoluble substrate gel at 37°C overnight. Various concentrations of the bone cell inhibitor were incubated with active collagenase (25 Mg/ml) at room temperature for 10 min; the reaction mixtures were then added to the collagen gels and incubated at 37°C for 3.5 hours. The reactions were stopped by adding 200 Ml of buffer followed by centrifugation at 9,000 g for 10 min. The supernatant fractions were then counted in a liquid scintillation spectrometer (Beckman Instruments, Inc., Palo Alto, CA). TIMP concentration in the partially purified bone media was determined by ELISA (21) .
RNA isolation and Northern blot analysis. Total cytoplasmic RNA was isolated by guanidinium isothiocyanate extraction according to established procedures (29). The total RNA was fractionated on a 1.2% agarose gel containing 2.2 M formaldehyde, transferred to nitrocellulose filters, and then hybridized to nick-translated human fibroblast collagenase (30) or human TIMP (31) cDNA probes. Autoradiography was performed using XAR-5 X-Omat AR film (Eastman Kodak Co., Rochester, NY) developed at -70°C.
Gelatin zymograms. To determine if human bone cells were capable of secreting metalloproteases with gelatin-degrading activity, aliquots of conditioned media were electrophoresed on 10% SDS-polyacrylamide substrate gels containing 1 mg/ml of gelatin (32) . Samples were diluted into an equal volume of sample buffer (2% SDS, 0.15% glycerol, 0.25 M Tris-HCl, pH 6.8, 0.1% bromphenol blue), loaded without boiling, and separated at 4°C. After electrophoresis, the gels were washed twice for 15 min in 2.5% Triton X-100, then once in a fresh solution of 50 mM Tris, pH 8.0, containing 5 mM CaCl2 and 1 mM ZnCl2. Gels were then incubated in the same buffer for 24 h at 37°C to allow for enzymatic digestion of the gelatin substrate. Proteolytic activity was visualized by staining the gels in 0.5% Coomassie blue R250 containing 30% isopropyl alcohol and 10% acetic acid, followed by destaining in water. This technique is extremely sensitive, results in separation of enzyme-TIMP complexes by the SDS, and provides M, information on the proteases with gelatinolytic activity.
Results
Characterization of human bone cells: alkaline phosphatase, bone gla protein, and cAMP production. Cultures obtained from bacterial collagenase digestion of human trabecular bone were characterized as osteoblastic by several criteria including high intrinsic alkaline phosphatase activity, secretion of BGP in response to vitamin D, and the capacity for PTH-stimulated cAMP production (2). Cultures were routinely assessed for alkaline phosphatase both histochemically and biochemically. Histochemical staining for alkaline phosphatase was strongly positive in 80.1±9.2% ofthe cells from the various bone preparations. Biochemical assay for alkaline phosphatase resulted in a mean activity±SE of 436.23±85 nmol/min per mg protein. serum-free medium. Furthermore, the human bone cells were also exposed to PTH, a bone-seeking hormone which is a potent stimulator of bone resorption (34), or PMA, a known stimulator of collagenase production by human fibroblasts (35, 36) . The conditioned media from the control and treated cultures were then assayed for interstitial collagenase and TIMP by ELISAs utilizing polyclonal antisera specific for each protein. The results (Table I) indicated that bone cells derived from the various bone specimens secreted only negligible or nondetectable amounts of collagenase, but did produce large quantities of TIMP. In some cases, both PTH and PMA appeared to notably enhance TIMP production as compared with control values. Furthermore, the amounts of TIMP secreted by neonatal-derived osteoblasts were often severalfold greater than those observed for the adult cells.
Exposure of serum-containing bone cell cultures (5 specimens) to recombinant IL-1/ likewise faile4 to stimulate the production of collagenase to measurable levels. Total cytoplasmic RNA isolated from these cultures lacked collagenasespecific mRNA as determined by Northern blot analysis (Fig.  1 A) . However, the same preparation of total RNA contained abundant TIMP mRNA, as shown in Fig. 1 B.
Stimulation of one specimen with IL-1 under serum-free conditions did provoke the secretion of a minimal amount of collagenase which was comparable to that seen with PMA (0.027 ,g/ml vs. 0.012 ug/ml, respectively). This bone-derived collagenase was a doublet species of Mr 57,52 kD, exhibiting identical electrophoretic migration to human fibroblast collagenase, as shown by subjecting the respective cell types to metabolic labeling and immunoprecipitation of secreted proteins using collagenase-specific antisera (Fig. 2) . The amount of collagenase secreted by this confluent bone cell culture was < 5% of the fibroblast production rate (Fig. 2) , as determined by densitometric scanning and ELISA. Two other bone cell cultures stimulated with IL-1 under serum-free conditions failed to produce immunologically detectable amounts of collagenase. Furthermore, when bone cell cultures (two specimens) were treated with 1,25(OH)2 vitamin D3, EGF, and combinations of PTH and 1,25(OH)2 vitamin D3, or EGF and 1,25(OH)2 vitamin D3 for 48 h, secretion of collagenase into conditioned media remained undetectable, whereas TIMP production was not consistently affected (data not shown).
Since significant amounts of collagenase were not released by bone cells during 24-72 h of incubation with agents that would be expected to stimulate enzyme secretion, conditioned media collected at earlier time points were also examined. Cultures were exposed to PTH and supernatants harvested at 4, 8, 16, 24, 48 , and 72 h. Again, no collagenase release was detectable at any time interval (data not shown), indicating that the cells were not secreting and recapturing the enzymea phenomenon previously suggested to occur in rat UMR-106 cells (14) . In contrast, TIMP was secreted in a nearly linear fashion by human bone cells in culture for periods up to 72 h (Fig. 3) .
Cell extracts examined at 4, 8, 16, 24, 48 , and 72 h did not contain immunologically detectable collagenase or TIMP. These data most likely reflect the secretory nature of TIMP. The lack of significant intracellular storage is consistent with previously described mechanisms of TIMP biosynthesis in fibroblasts and macrophages (21, 23, 37) .
Human osteoblast TIMP is immunologically identical to human fibroblast TIMP. A double-immunodiffusion assay performed with pure human fibroblast TIMP, partially puri- meric type I collagen in solution and '4C-labeled collagen fibrils as substrate. Conditioned media samples, concentrated as described in Methods, were derived from bone cell cultures stimulated with PTH, vitamin D, phorbol ester, or combinations thereof. The concentrated samples were assayed with and without exposure to organomercurial compounds or trypsin, agents previously shown to activate the zymogen forms of metalloproteinases secreted by human mesenchymal cells (27, 38) . The results (data not shown) provided no evidence of type I collagenolytic activity under any condition tested. Bone cell-derived TIMP was tested for its functional ability to inhibit human fibroblast collagenase. Increasing amounts of partially purified bone-conditioned media were incubated with pure fibroblast collagenase and the resultant collagenolytic activity was measured against '4C-labeled collagen fibrils at 37°C. TIMP present in bone conditioned media was quantified using an ELISA to human fibroblast TIMP. As shown in Fig. 6 , the results of this titration indicated that bone-derived TIMP inhibited human collagenase in a stoichiometric manner, with full inhibition observed at a molar ratio of inhibitor:enzyme 1:1. Quantification of human osteoblast TIMP production compared with TIMP production by human fibroblasts. The capacity for production of TIMP by human osteoblasts vs human fibroblasts is shown in Table II . Since osteoblasts are severalfold larger than fibroblasts in cell size and cell volume, the data have been expressed in terms of total cellular protein to account for these differences. Fibroblasts were treated with phorbol esters to maximally stimulate their production of both TIMP and collagenase. Osteoblasts were exposed to IL-1 or PMA, although neither agent consistently stimulated TIMP or collagenase expression. As seen in Table II , secretion of TIMP by human osteoblasts was twofold that of maximal fibroblast production rates. In sharp contrast, there was no spontaneous secretion of collagenase by human osteoblasts and the highest stimulated levels observed were only 1-2% of fibroblast values.
Bone cells secrete other metalloproteinases. To assess the capacity of human bone cells to secrete metalloproteinases other than collagenase, conditioned media were subjected to gelatin substrate SDS-PAGE. The results (Fig. 7) indicate that human bone cells secrete a proteinase with major gelatinolytic activity of Mr -68 kD. This corresponds to the principal secreted gelatinolytic activity of human fibroblasts (Fig. 7) .
Furthermore, the confluent bone cell cultures appeared to secrete quantities of this gelatinolytic activity similar to those from confluent fibroblasts. This proteolytic capacity was completely abolished by EDTA (data not shown). The identity of this bone cell-derived gelatinolytic activity with human fibroblast gelatinase was further established by metabolic labeling of the respective cell types with [35S]methionine and subsequent immunoprecipitation of the labeled conditioned media using specific antisera directed against human skin fibroblast 68-kD gelatinase (39) , which demonstrated the synthesis of identical protein species by both cell types (Fig. 8) genase, they can secrete other metalloproteinases which may be involved in matrix turnover.
Discussion
The mechanism(s) by which osteoid is removed from the bone surface, prior to osteoclastic resorption ofbone, is still unclear. Several reports have indicated that highly enriched populations of osteoblasts, derived from rodent bone, synthesize and secrete collagenase after exposure to bone-resorbing agents such as PTH and PGE2 (15) (16) (17) (18) (40) (41) (42) . These findings raised the question of whether human osteoblasts responded to bone-resorbing agents in a like manner to rodent osteoblasts by the secretion of a neutral interstitial collagenase. Our findings indicate that, under the conditions tested, highly enriched populations of human osteoblasts in monolayer culture do not secrete significant quantities of collagenase in response to bone-seeking hormones including agents which have been shown to stimulate either bone formation or bone resorption.
Our search for a bone cell-derived interstitial collagenase was conducted utilizing both immunologic approaches and assays of functional activity. The mainstay of our immunologic methods was an ELISA for human skin fibroblast colla- genase that uses specific polyclonal antisera. Such antibody preparations have been employed in the past to demonstrate that human fibroblasts of diverse tissue origin (43), mononuclear phagocytes including peripheral blood monocytes (44) and alveolar macrophages (37) , and smooth muscle cells (45) all produce procollagenase species immunologically identical to human skin fibroblast collagenase. This ELISA has a sensitivity of 5 ng/ml, and yet human bone cell cultures released only occasionally detectable levels of collagenase under stimulated conditions (IL-1 and PMA, but not PTH), amounts trivial relative to fibroblast production (Table II) . Metabolic labeling and immunoprecipitation experiments confirmed the production of 57,52-kD procollagenase species by these stimulated bone cell cultures, but again in comparatively minor amounts (Fig. 2) . Furthermore, pure human fibroblast procollagenase added exogenously to the bone cell cultures under serum-containing or serum-free conditions for 48 h (± stimulatory agents) was fully detectable by ELISA after the incubation period. Therefore, collagenase was not being secreted and subsequently destroyed in this culture system (data not shown).
Nevertheless, the possibility existed that human osteoblasts synthesized and secreted a collagenase distinct from that secreted by most human mesenchymally derived cells. In this regard, neutrophils have been shown to contain within their specific granules a neutral, interstitial collagenase that is imOb P-I Fib Figure 8 (39) . Note the production of identical species from both the bone cells (Ob) and fibroblasts (Fib). Immunoprecipitation with preimmune antisera is designated as "P-I."
Human Osteoblast Tissue Inhibitor ofMetalloproteinases 691 0 o oI munologically and functionally distinct from the fibroblast/ macrophage enzyme (46, 47) . To investigate the possibility that human bone cells secreted a unique collagenase, the conditioned media from stimulated cultures were subjected to assays of functional collagenolytic activity. Before assay, the media were concentrated and subjected to two methods of activation, trypsin treatment or mercurial treatment, both previously shown to activate latent metalloproteinases secreted in zymogen form (27, 38) . Both cell supernates and extracts were analyzed in this manner, but functional collagenase activity could not be detected against native, soluble type I collagen or biosynthetically labelled type I collagen fibrils. These results were not affected by exposure ofbone cells to phorbol esters, a potent stimulator of collagenase production by fibroblasts (35, 36) , and furthermore, by exposure to PTH, vitamin D, or combinations of these agents, potent stimulators ofbone resorption in vitro (34). Nevertheless, it should be remembered that the presence of TIMP in cell supernates could serve to obscure the detection of metalloproteinasebased collagenolytic activity.
In contrast to the relative lack of human osteoblast secretion of interstitial collagenase, such cells released very substantial quantities of TIMP, both constitutively and after exposure to bone-resorbing agents. The bone cell TIMP was found to be identical to TIMP secreted by human fibroblasts in double immunodiffusion assays (Fig. 4) , after metabolic labeling of the cells and immunoprecipitation using TIMPspecific antisera (Fig. 5) , and in Northern blot analysis (Fig. 1   B) . Furthermore, the bone cell TIMP possessed stoichiometric collagenase inhibitory capacity equivalent to fibroblast TIMP as determined by titration against pure human collagenase (Fig. 6 ). An intriguing observation in this study was that cells derived from bone ofvarious individuals responded differently to stimulation by PTH (Table I) , PMA (Table I) , and also IL-l (not shown) in their secretion of TIMP. Although the extremely slow growth of these bone cells and small numbers available prevented a rigorous examination of TIMP regulation in the present study, it seemed clear that some cultures showed no rise in TIMP secretion while others demonstrated severalfold increases. This individual variability may have important implications in the process of bone resorption and in the natural course of metabolic bone diseases such as osteoporosis, which leads to some individuals losing bone at a slower rate than others within the same age group. Indeed, we have recently reported that elevated levels of IL-l are associated with high bone formation rates in some individuals with idiopathic osteoporosis (48) . These individuals were also found to have accelerated bone loss as judged by computed axial tomography ofthe vertebral spine. Thus, the ability ofbone cells to respond to bone-resorbing agents by increasing inhibitor production may decrease bone loss while the lack ofa response could increase bone loss.
Human 7 and 8) , and represents a metal-dependent enzyme that has very recently been purified and cloned (39) . In addition to denatured collagen, this enzyme has a limited capacity to cleave other extracellular matrix constituents including native types IV and V collagen, but not type I collagen (39) . Its function in bone remodelling is presently unclear but demands further investigation.
The results reported herein raise new questions as to the mechanism of bone resorption in the human as compared to the rodent. Our findings of high levels of TIMP and gelatinase expression by human bone cells contrast sharply with the nonexistent or extremely low levels of secreted collagenase. Although a lack of collagenase activity from human osteoblasts after stimulation with purified IL-I has been previously reported (50), we have utilized extremely sensitive and specific immunologic probes and have expanded the range of possible stimulators of collagenase secretion to examine human bone cell collagenase production by bone-resorbing agents. Many of the agents tested in this report have been found to stimulate collagenase release from rodent osteoblasts leading to the conclusion that bone cells play a major role in the process ofbone resorption by preparing the bone surface for osteoclast attachment. We must conclude, however, that this model may not apply to the process of bone resorption in the human. Indeed, the very agents which would have been expected to stimulate collagenase production in human cells instead stimulated (al-beit inconsistently) the synthesis and secretion of TIMP, perhaps suggesting a protective response by the bone cells to stimulators of bone resorption. Thus, we must postulate that cells within the local environment of bone other than osteoblasts, such as macrophages, are possible sources ofthe collagenolytic activity which has been suggested as necessary for the removal of uncalcified osteoid prior to osteoclastic attachment to the bone, should such a phenomenon be necessary to occur. Since the aforementioned cells do not have PTH receptors, we must further postulate that PTH may induce osteoblasts to secrete a factor(s) which both activates such cells to release collagenolytic activity at the site of bone resorption and also induces resorption of mineralized bone by osteoclasts as suggested by McSheehy and Chambers (51, 52) and Thompson et al. (53) . In any event, the secretion of TIMP by the bone cells may indeed reflect a protective mechanism to control the amount of osteoid loss. This may account for the existence of only minute foci of osteoclastic action observed in histological sections of bone.
